TVC launches resource for low vision patients and caregivers

Article

New Web site from The Vision Council aims to educate consumers about low vision.

Alexandria, VA-The Vision Council (TVC) has launched a standalone Web site, www.hatislowvision.org, dedicated to educating consumers about low vision and low vision solutions.

The site was created as a resource for people with vision impairment due to macular degeneration, diabetic retinopathy, glaucoma, and other eye conditions associated with aging. It is fully functional for low vision users. The Web initiative can help answer questions that people with low vision, plus their loved ones and caregivers, may have by addressing its causes and warning signs, as well as vision-enhancing devices and treatments.

Maureen Beddis, vice president of marketing and communications for TVC, said: “During the past year we have been collaborating with key groups in the vision and caregiving communities toward the common goal of raising awareness for low vision and increasing knowledge of low vision solutions for improving quality of life. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.